Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.

MLA

Laurén, Ida, et al. “Long-Term SARS-CoV-2-Specific and Cross-Reactive Cellular Immune Responses Correlate with Humoral Responses, Disease Severity, and Symptomatology.” Immunity, Inflammation and Disease, vol. 10, no. 4, Apr. 2022, p. e595. EBSCOhost, https://doi.org/10.1002/iid3.595.

APA

Laurén, I., Havervall, S., Ng, H., Lord, M., Pettke, A., Greilert-Norin, N., Gabrielsson, L., Chourlia, A., Amoêdo-Leite, C., Josyula, V. S., Eltahir, M., Kerzeli, I., Falk, A. J., Hober, J., Christ, W., Wiberg, A., Hedhammar, M., Tegel, H., Burman, J., … Mangsbo, S. (2022). Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology. Immunity, Inflammation and Disease, 10(4), e595. https://doi.org/10.1002/iid3.595

Chicago

Laurén, Ida, Sebastian Havervall, Henry Ng, Martin Lord, Aleksandra Pettke, Nina Greilert-Norin, Lena Gabrielsson, et al. 2022. “Long-Term SARS-CoV-2-Specific and Cross-Reactive Cellular Immune Responses Correlate with Humoral Responses, Disease Severity, and Symptomatology.” Immunity, Inflammation and Disease 10 (4): e595. doi:10.1002/iid3.595.